The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 119, Issue 21, Pages -
Publisher
Proceedings of the National Academy of Sciences
Online
2022-05-17
DOI
10.1073/pnas.2200413119
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Type I interferons and SARS-CoV-2: from cells to organisms
- (2022) Paul Bastard et al. CURRENT OPINION IN IMMUNOLOGY
- Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome
- (2022) Hassan Abolhassani et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Human genetic and immunological determinants of critical COVID-19 pneumonia
- (2022) Qian Zhang et al. NATURE
- Why do people die from COVID-19?
- (2022) Paul Bastard SCIENCE
- COVID-19 convalescent plasma composition and immunological effects in severe patients
- (2021) Yeny Acosta-Ampudia et al. JOURNAL OF AUTOIMMUNITY
- Immune determinants of COVID-19 disease presentation and severity
- (2021) Petter Brodin NATURE MEDICINE
- COVID-19 and the human innate immune system
- (2021) Joachim L. Schultze et al. CELL
- Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine
- (2021) Paul Bastard et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients
- (2021) Rutger Koning et al. INTENSIVE CARE MEDICINE
- Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma
- (2021) Sara E. Vazquez et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain
- (2021) Jesús Troya et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2
- (2021) Paul Bastard et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1
- (2021) Paul Bastard et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Diverse Functional Autoantibodies in Patients with COVID-19
- (2021) Eric Y. Wang et al. NATURE
- Natural mucosal barriers and COVID-19 in children
- (2021) Carl A. Pierce et al. JCI Insight
- Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19
- (2021) Carly G.K. Ziegler et al. CELL
- The interferon landscape along the respiratory tract impacts the severity of COVID-19
- (2021) Benedetta Sposito et al. CELL
- Neutralizing type‐I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID‐19
- (2021) Michael S Abers et al. IMMUNOLOGY AND CELL BIOLOGY
- Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β
- (2021) Donald C. Vinh et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
- (2021) Jonathan Lopez et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
- (2021) Monique G. P. van der Wijst et al. Science Translational Medicine
- New-onset IgG autoantibodies in hospitalized patients with COVID-19
- (2021) Sarah Esther Chang et al. Nature Communications
- TBK1 and TNFRSF13B mutations and an autoinflammatory disease in a child with lethal COVID-19
- (2021) Axel Schmidt et al. npj Genomic Medicine
- Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
- (2021) Paul Bastard et al. Science Immunology
- X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19
- (2021) Takaki Asano et al. Science Immunology
- Temporal Dynamics of Anti-Type 1 Interferon Autoantibodies in COVID-19 Patients
- (2021) Elana R Shaw et al. CLINICAL INFECTIOUS DISEASES
- Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19
- (2021) Matthijs P. Raadsen et al. JOURNAL OF CLINICAL IMMUNOLOGY
- A Case of Autosomal Recessive Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency with Severe COVID-19
- (2021) Shaghayegh Khanmohammadi et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona
- (2021) Xavier Solanich et al. JOURNAL OF CLINICAL IMMUNOLOGY
- X-Linked TLR7 Deficiency Underlies Critical COVID-19 Pneumonia in a Male Patient with Ataxia-Telangiectasia
- (2021) Hassan Abolhassani et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Mechanisms of viral inflammation and disease in humans
- (2021) Jean-Laurent Casanova et al. SCIENCE
- Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort
- (2021) Raphael Carapito et al. Science Translational Medicine
- Microarray-Based Detection of Antibodies against SARS-CoV-2 Proteins, Common Respiratory Viruses and Type I Interferons
- (2021) Elena Savvateeva et al. Viruses-Basel
- Lethal Infectious Diseases as Inborn Errors of Immunity: Toward a Synthesis of the Germ and Genetic Theories
- (2020) Jean-Laurent Casanova et al. Annual Review of Pathology-Mechanisms of Disease
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection
- (2020) Jean-Laurent Casanova et al. CELL
- Autoantibodies against cytokines: phenocopies of primary immunodeficiencies?
- (2020) Chen-Lung Ku et al. HUMAN GENETICS
- Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
- (2020) Benjamin Israelow et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Quantification and interpretation of attributable mortality in core clinical infectious disease journals
- (2020) Maja von Cube et al. LANCET INFECTIOUS DISEASES
- Characteristics of SARS-CoV-2 and COVID-19
- (2020) Ben Hu et al. NATURE REVIEWS MICROBIOLOGY
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Genetic Lesions of Type I Interferon Signalling in Human Antiviral Immunity
- (2020) Christopher J.A. Duncan et al. TRENDS IN GENETICS
- Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications
- (2020) Andrew T. Levin et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison
- (2020) Ioanna-Evdokia Galani et al. NATURE IMMUNOLOGY
- REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
- (2020) David M. Weinreich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Phillip D Monk et al. Lancet Respiratory Medicine
- Plasmacytoid dendritic cell and myeloid dendritic cell function in ageing: A comparison between elderly and young adult women
- (2019) Marloes van Splunter et al. PLoS One
- Blockade of Interferon Beta, but Not Interferon Alpha, Signaling Controls Persistent Viral Infection
- (2015) Cherie T. Ng et al. Cell Host & Microbe
- Nocardia-Induced Granulocyte Macrophage Colony-Stimulating Factor Is Neutralized by Autoantibodies in Disseminated/Extrapulmonary Nocardiosis
- (2014) Lindsey B. Rosen et al. CLINICAL INFECTIOUS DISEASES
- The JAK-STAT Pathway at Twenty
- (2012) George R. Stark et al. IMMUNITY
- Evolutionary genetic dissection of human interferons
- (2011) Jérémy Manry et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I
- (2010) Anne Puel et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines
- (2010) Kai Kisand et al. JOURNAL OF EXPERIMENTAL MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started